BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2008
View Archived Issues
Antitumor activity reported for WP-1193 in brain tumor cells
Read More
Talampanel safe when added to radiotherapy and temozolomide in glioblastoma patients
Read More
Phase II studies show romidepsin monotherapy is active in peripheral and cutaneous T-cell lymphomas
Read More
Novavax reports top-line results from phase IIa influenza vaccine trial
Read More
Evidence of pharmacodynamic activity seen for triciribine in phase I trial
Read More
Clinical data show efficacy for bosutinib in chronic myelogenous leukemia
Read More
AEterna Zentaris completes patient recruitment into phase III safety trial of cetrorelix in BPH
Read More
Delcath enrolls 50% of patients in metastatic melanoma phase III clinical trial of PHP system
Read More
Merck & Co. initiates phase I clinical development of estrogen receptor compound
Read More
Synta earns USD 15 million in milestone payments from GSK for development of elesclomol
Read More
Theratechnologies reports results from phase III clinical trial of tesamorelin
Read More
FibroGen initiates phase I FG-3019 trial in patients with pancreatic cancer
Read More
Eldecalcitol reduces incidence of new vertebral fractures in phase III trial
Read More
EntreMed focuses resources on development of ENMD-2076
Read More
Peplin completes enrollment for its first phase III PEP-005 trial in actinic keratosis
Read More
QLT reports interim results of phase II Visudyne combination therapy study
Read More
Adlea significantly reduces pain after total knee replacement in phase III trial
Read More
Basilea commences U.S. phase III study for alitretinoin in severe hand eczema
Read More
New agents for arthritis reported in recent patents
Read More
FDA accepts Transcept's Intermezzo NDA for review
Read More
Lundbeck initiates phase III trials with desmoteplase in ischemic stroke
Read More
Naproxcinod shows robust blood pressure results in phase III pooled analysis
Read More
NX-1207 shows significantly less sleep interruption for men with BPH
Read More
Recent patents divulge novel analgesic agents
Read More
New agents for psychiatric disorders described in recent Lilly and NeuroSearch patents
Read More